{"id":3840,"date":"2020-08-26T09:17:22","date_gmt":"2020-08-26T09:17:22","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/capillary-electrophoresis-analyser-now-connected-to-lab-automation-system\/"},"modified":"2021-01-08T11:21:01","modified_gmt":"2021-01-08T11:21:01","slug":"capillary-electrophoresis-analyser-now-connected-to-lab-automation-system","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/capillary-electrophoresis-analyser-now-connected-to-lab-automation-system\/","title":{"rendered":"Capillary electrophoresis analyser now connected to lab automation system"},"content":{"rendered":"<p>Sebia\u2019s latest generation instrument, Capillarys 3 TERA, is now connectable to the Inpeco automation systems, available under the FlexLab brand name and as Aptio by Siemens. This analyser offers a large menu of tests for the diagnosis and follow-up of myeloma, diabetes and hemoglobin disorders. Two assays are now connectable to Inpeco automation: HbA1c and Serum Protein Electrophoresis. Other tests such as Serum Immunotyping and Hemoglobin electrophoresis will follow soon.<br \/>The Capillarys 3 TERA TLA connection with FlexLab opens new opportunities for lab automation and brings the capillary electrophoresis analyser closer to the core clinical laboratory workflow. Designed as a point-of-space connection, Capillarys 3 TERA TLA can process serum and whole blood at the same time thanks to a specific development on FlexLab.<br \/>\n<!--more--><br \/>\n<strong>Supplier:<\/strong> Sebia<br \/>\n<strong>Website:<\/strong> <a href=\"\" target=\"_blank\" rel=\"noopener noreferrer\"><\/a><\/p>\n<p><a class=\"avia-button avia-color-theme-color\" href=\"mailto:cbrondy@sebia.com\">Mail the supplier<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sebia\u2019s latest generation instrument, Capillarys 3 TERA, is now connectable to the Inpeco automation systems, available under the FlexLab brand name and as Aptio by Siemens. This analyser offers a large menu of tests for the diagnosis and follow-up of myeloma, diabetes and hemoglobin disorders. Two assays are now connectable to Inpeco automation: HbA1c and [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":10649,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39],"tags":[],"class_list":["post-3840","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product-news"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/3840"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=3840"}],"version-history":[{"count":0,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/3840\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/10649"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=3840"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=3840"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=3840"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}